Literature DB >> 24995098

Clinical observation of laparoscopic radical hysterectomy for cervical cancer.

Xiang-Hua Yin1, Zhong-Qin Wang1, Shi-Zhang Yang1, Hong-Yan Jia1, Min Shi1.   

Abstract

To evaluate safety, feasibility and the improvement of surgical method of laparoscopic extensive hysterectomy and pelvic lymph node dissection in patients with early-stage cervical cancer. Clinical data were prospectively collected from patients with IA2-IIA cervical cancer who underwent laparoscopic extensive hysterectomy (n1=22) and laparotomy (n2=23) in Department of Obstetrics and Gynecology in the Subei People's Hospital from June 2010 to August 2013. The successful rates in two groups of operation were 100%. Blood loss, postoperative hospital stay, complication rate, postoperative recovery of gastrointestinal tract and bladder function of the laparoscopy group of the laparoscopic group were all better than those of the laparotomy group, and there were significant differences (all P < 0.05). But in the laparoscopy group, the operative time was longer than the laparotomy group with statistical significance (P < 0.05). There was no statistically significant difference in the number of excised lymph nodes and the duration time of postoperative urinary catheterization between the two groups (P > 0.05). Laparoscopic extensive hysterectomy and pelvic lymph node dissection can fully meet the requirement of laparotomy. It has the properties of minor trauma and rapid recovery. The clinical efficacy is superior to laparotomy surgery. The results indicated laparoscopic is an ideal method for the treatment of early cervical cancer.

Entities:  

Keywords:  Laparoscopic surgery; cervical cancer; clinical efficacy

Year:  2014        PMID: 24995098      PMCID: PMC4073759     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  15 in total

1.  Estimating the world cancer burden: Globocan 2000.

Authors:  D M Parkin; F Bray; J Ferlay; P Pisani
Journal:  Int J Cancer       Date:  2001-10-15       Impact factor: 7.396

2.  Long-term survival outcomes of laparoscopically assisted radical hysterectomy in treating early-stage cervical cancer.

Authors:  Chyi-Long Lee; Kai-Yun Wu; Kuan-Gen Huang; Pei-Shan Lee; Chih-Feng Yen
Journal:  Am J Obstet Gynecol       Date:  2010-05-11       Impact factor: 8.661

3.  Total laparoscopic radical trachelectomy in the treatment of early squamous cell cervical cancer: a retrospective study with 8-year follow-up.

Authors:  Qi Lu; Yunhe Zhang; Chongdong Liu; Shuzhen Wang; Shuli Guo; Zhenyu Zhang
Journal:  Gynecol Oncol       Date:  2013-05-04       Impact factor: 5.482

Review 4.  Treatments for gynaecological cancers.

Authors:  Sean Kehoe
Journal:  Best Pract Res Clin Obstet Gynaecol       Date:  2006-08-08       Impact factor: 5.237

5.  A case-controlled study of total laparoscopic radical hysterectomy with pelvic lymphadenectomy versus radical abdominal hysterectomy in a fellowship training program.

Authors:  K Zakashansky; L Chuang; H Gretz; N P Nagarsheth; J Rahaman; F R Nezhat
Journal:  Int J Gynecol Cancer       Date:  2007-03-26       Impact factor: 3.437

6.  Early cervical cancer managed by laparoscopy and conventional surgery: comparison of treatment results.

Authors:  Piotr Sobiczewski; Mariusz Bidzinski; Pawel Derlatka; Grzegorz Panek; Anna Danska-Bidzinska; Leszek Gmyrek; Wojciech Michalski
Journal:  Int J Gynecol Cancer       Date:  2009-11       Impact factor: 3.437

7.  Comparative evaluation of surgical stress of laparoscopically assisted vaginal radical hysterectomy and lymphadenectomy and laparotomy for early-stage cervical cancer.

Authors:  Cai-Ying Hou; Xiu-Li Li; Feng Jiang; Rong Jie Gong; Xin Yu Guo; Yuan-Qing Yao
Journal:  Oncol Lett       Date:  2011-05-13       Impact factor: 2.967

8.  Complications of laparoscopic radical hysterectomy and pelvic lymphadenectomy--experience of 117 patients.

Authors:  Xiaojian Yan; Guangyi Li; Huilin Shang; Gang Wang; Lushi Chen; Yubin Han
Journal:  Int J Gynecol Cancer       Date:  2009-07       Impact factor: 3.437

9.  Survival for stage IB cervical cancer with positive lymph node involvement: a comparison of completed vs. abandoned radical hysterectomy.

Authors:  Scott D Richard; Thomas C Krivak; Anthony Castleberry; Sushil Beriwal; Joseph L Kelley; Robert P Edwards; Paniti Sukumvanich
Journal:  Gynecol Oncol       Date:  2008-01-29       Impact factor: 5.482

10.  Total laparoscopic radical hysterectomy versus abdominal radical hysterectomy with lymphadenectomy in patients with early cervical cancer: our experience.

Authors:  Mario Malzoni; Raffaele Tinelli; Francesco Cosentino; Annarita Fusco; Carmine Malzoni
Journal:  Ann Surg Oncol       Date:  2009-02-18       Impact factor: 5.344

View more
  4 in total

1.  Raloxifene suppress proliferation-promoting function of estrogen in CaSKi cervical cells.

Authors:  Jing-Quan Ma; Xing-Hua Wang; Li-Ping Tang; Xiu-Wei Chen; Ge Lou
Journal:  Int J Clin Exp Med       Date:  2015-04-15

2.  Impact of hospital care volume on clinical outcomes of laparoscopic radical hysterectomy for cervical cancer: A systematic review and meta-analysis.

Authors:  Banghyun Lee; Kidong Kim; Youngmi Park; Myong Cheol Lim; Robert E Bristow
Journal:  Medicine (Baltimore)       Date:  2018-12       Impact factor: 1.817

3.  Digital Immune-Related Gene Expression Signatures In High-Grade Serous Ovarian Carcinoma: Developing Prediction Models For Platinum Response.

Authors:  Fabian Mairinger; Agnes Bankfalvi; Kurt Werner Schmid; Elena Mairinger; Pawel Mach; Robert Fh Walter; Sabrina Borchert; Sabine Kasimir-Bauer; Rainer Kimmig; Paul Buderath
Journal:  Cancer Manag Res       Date:  2019-11-12       Impact factor: 3.989

4.  CAF-Associated Paracrine Signaling Worsens Outcome and Potentially Contributes to Chemoresistance in Epithelial Ovarian Cancer.

Authors:  Michael Wessolly; Elena Mairinger; Sabrina Borchert; Agnes Bankfalvi; Pawel Mach; Kurt Werner Schmid; Rainer Kimmig; Paul Buderath; Fabian Dominik Mairinger
Journal:  Front Oncol       Date:  2022-03-03       Impact factor: 6.244

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.